Jeffs Roger
SEC-identified person · CIK 1231615 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | Director | filed 2015 - 2026 |
| Liquidia Corp LQDA | Director · Chief Executive Officer | filed 2020 - 2026 |
| Biodel Inc BIODEL | Director | filed 2017 - 2021 |
| Dova Pharmaceuticals, Inc. DOVA | Director | filed 2017 - 2019 |
| Sio Gene Therapies Inc. SIOX | Director | filed 2018 - 2019 |
| Sangamo Therapeutics, INC SGMO | Director | filed 2017 - 2018 |
| United Therapeutics Corp uthr | Director · President and COO | filed 2006 - 2016 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.